ArticleCancers2023
DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC.
Nanbin Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleCancers2023
Nanbin Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.